Which biotech companies are performing the Night of the Long Knives, who benefits from HS2 and is blockchain the revolution that hasn't quite happened, but is on the verge of being understood? Sarah talks ledgers, management reshuffles at E Therapeutics and whether AstraZeneca and RBS shareholders will be feeling the love on Valentines Day.